Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Gynaecological Cancers

ESMO-Congress-2023-Banner-1000x250px

Saturday 21 October

Convergence of Evidence and Experience in First-Line Advanced Ovarian Cancer. Experts Debate Considerations and Options for Optimized Clinical Management

21-Convergence-of-Evidence-and-Experience-in-First-Line-Advanced-Ovarian-GSK-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Sunday 22 October

The Breakthrough Era in Endometrial Cancer Treatment

36-The-Breakthrough-Era-in-Endometrial-Cancer-Treatment-GSK-thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Detection of Homologous Recombination Deficiency (HRD): Role of HRD Testing and Impact on Patient Management

40-Detection-of-Homologous-Recombination-Deficiency-HRD-ILLUMINA-Thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 23 October

The Evolving Role of TTFields Therapy in Solid Tumors

51-The-Evolving-Role-of-TTFields-Therapy-in-Solid-Tumors-NOVOCURE-thumb

Monday, 13:00 - 14:30
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.